These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide. Winkle RA; Peters F; Kates RE; Harrison DC Am J Cardiol; 1983 Apr; 51(7):1182-8. PubMed ID: 6404150 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study. Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017 [TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of oral encainide in frequent and repetitive ventricular arrhythmias. Bongiorni MG; Levorato D; Arlotta C; Paperini L; Contini C Eur Heart J; 1988 Jul; 9(7):765-76. PubMed ID: 3139413 [TBL] [Abstract][Full Text] [Related]
7. Response to encainide of refractory ventricular tachycardia: clinical application of assays for parent drug and metabolites. Anderson JL; Stewart JR; Johnson TA; Lutz JR; Pitt B J Cardiovasc Pharmacol; 1982; 4(5):812-9. PubMed ID: 6182414 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias. Winkle RA; Peters F; Kates RE; Tucker C; Harrison DC Circulation; 1981 Aug; 64(2):290-6. PubMed ID: 6788400 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. Morganroth J; Somberg JC; Pool PE; Hsu PH; Lee IK; Durkee J; Salerno DM J Am Coll Cardiol; 1986 Jan; 7(1):9-16. PubMed ID: 3079781 [TBL] [Abstract][Full Text] [Related]
10. Encainide: a new antiarrhythmic agent. Wehmeyer AE; Thomas RL Drug Intell Clin Pharm; 1986 Jan; 20(1):9-13. PubMed ID: 3080301 [TBL] [Abstract][Full Text] [Related]
11. Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies. DiBianco R; Fletcher RD; Cohen AI; Gottdiener JS; Singh SN; Katz RJ; Bates HR; Sauerbrunn B Circulation; 1982 Jun; 65(6):1134-47. PubMed ID: 6804110 [TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia. Mason JW; Peters FA Circulation; 1981 Mar; 63(3):670-5. PubMed ID: 6780234 [TBL] [Abstract][Full Text] [Related]
13. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics. Roden DM; Reele SB; Higgins SB; Mayol RF; Gammans RE; Oates JA; Woosley RL N Engl J Med; 1980 Apr; 302(16):877-82. PubMed ID: 6767186 [TBL] [Abstract][Full Text] [Related]
14. Relation of blood level and metabolites to the antiarrhythmic effectiveness of encainide. Harrison DC; Kates RE; Quart BD Am J Cardiol; 1986 Aug; 58(5):66C-73C. PubMed ID: 3092622 [TBL] [Abstract][Full Text] [Related]
15. Encainide for cardiac arrhythmias. Med Lett Drugs Ther; 1987 May; 29(740):50-2. PubMed ID: 2437434 [No Abstract] [Full Text] [Related]
16. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation. Roden DM; Lee JT; Woosley RL; Echt DS Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262 [TBL] [Abstract][Full Text] [Related]
17. Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals. Carey EL; Duff HJ; Roden DM; Primm RK; Wilkinson GR; Wang T; Oates JA; Woosley RL J Clin Invest; 1984 Feb; 73(2):539-47. PubMed ID: 6421879 [TBL] [Abstract][Full Text] [Related]
18. Sinus node dysfunction and sudden cardiac death following treatment with encainide. Lemery R; Talajic M; Nattel S; Theroux P; Roy D Pacing Clin Electrophysiol; 1989 Oct; 12(10):1607-12. PubMed ID: 2477816 [TBL] [Abstract][Full Text] [Related]
19. Comparison of twice daily with thrice daily administered encainide for benign or potentially lethal ventricular arrhythmias. Hohnloser SH; Zabel M; Zehender M; Meinertz T; Just H Am J Cardiol; 1989 Jan; 63(1):73-6. PubMed ID: 2462343 [TBL] [Abstract][Full Text] [Related]
20. Treatment of ectopic atrial arrhythmias and premature atrial complexes in adults with encainide. Pool PE; Quart BD Am J Cardiol; 1988 Dec; 62(19):60L-62L. PubMed ID: 2462340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]